Treating alcohol addiction: filling the medication gap
With Dry January firmly behind us, many adults are prompted to reassess their relationship with alcohol. Alcohol Change, the UK…
With Dry January firmly behind us, many adults are prompted to reassess their relationship with alcohol. Alcohol Change, the UK…
The year ahead in clinical trials looks set to be one that is challenged and influenced by regulatory developments, new…
Kindeva Drug Delivery division Meridian Medical Technologies has won a new contract worth up to $129m from the US Government…
Two years have passed since the US Supreme Court’s decision in Dobbs vs Jackson Women’s Health to overturn the constitutional…
Several pharmaceutical companies are advancing dry powder inhalers (DPIs) for respiratory conditions in an effort to cut down on greenhouse…
The Pharmaceutical Automation and Digitalisation Congress (AUTOMA+) 2024 is a strategic platform for discussion and collaboration among decision makers, researchers…
The growing global demand for cell and gene therapies (CGTs) is resulting in a manufacturing paradigm shift, reflecting the need…
With the approval date for Bristol Myers Squibb’s (BMS) schizophrenia drug KarXT (xanomeline-trospium) looming, prodrugs – medications that start as…
Astria Therapeutics has selected Ypsomed’s Ypsomate autoinjector as its partner for the administration of STAR-0215 for the treatment of hereditary…
US-based Leap Consulting Group has launched a practice aimed at guiding Clinical Laboratory Improvement Amendments-certified labs (CLIA) in adhering to…